Fundraising FoxAlexandria — 2017 Investments
8 investments dated 2017 · listed companies and verified rows first · show all
Amgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US
Sanford Markowitz(Director)William K. Bowes(Founder)George B. Rathmann(First CEO)David Piacquad(Executive Officer)Brian M. McNamee(Executive Officer)inRobert A. Bradway(Executive Officer, Director)
Co-investorsAsset Management CompanyBOMBoulder VenturesCWRU Technology VenturesIndustrifondenMayfield Fund+5 more
EVELO manufactures premium electric bikes designed for comfort and long-distance riding, sold direct-to-consumer with industry-leading warranty and support.
ConsumerDirect to ConsumerE-commerceHardwareMobility & TransportationSeattle, US
Yevgeniy Mordkovich(Executive Officer, Director)inBoris Mordkovich
Co-investorsForefront VentureFlagship PioneeringGV (Google Ventures)Kaiser Permanente Ventures
Nexoplex Bio develops immunotherapies that target tumor cells through recognition of HLA-peptide complexes using multi-specific antibodies, addressing tumor types including lung, gastric, esophageal, head and neck, cervical cancers, and lung squamous cell carcinoma.
BiotechDeep TechHealthtechSan Carlos, US
Wayne(CEO)Rachel(VP of Operations)
Co-investorsBay City CapitalGV (Google Ventures)LAVLilly Asia VenturesFrazier Healthcare PartnersThe Column Group+1 more
Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.
BiotechBedford, US
Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)
BoardSteven Gillis(Director)Arthur Tzianabos(Executive Officer, Director)Kush Parmar(Director)inRichard Gregory(Director)
Co-investors5AM VenturesARCH Venture PartnersOUP (Osage University Partners)Deerfield Management CompanyFidelity InvestmentsHBM Healthcare Investments+5 more
LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
AI & Machine LearningBiotechDeep TechCambridge, US
Gregory L. Verdine(Executive Officer, Director)Gregory Verdine, Ph.D.
BoardHingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)
Co-investorsARCH Venture PartnersGV (Google Ventures)RA CapitalAisling CapitalBezos ExpeditionsBlue Pool Capital+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.